NASDAQ:DOMH Dominari (DOMH) Stock Price, News & Analysis → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free DOMH Stock Alerts $2.05 -0.07 (-3.30%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$2.04▼$2.3650-Day Range$1.95▼$3.1452-Week Range$1.76▼$3.40Volume7,589 shsAverage Volume11,655 shsMarket Capitalization$12.16 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Dominari alerts: Email Address Dominari MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.01% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.32Based on 5 Articles This WeekInsider TradingAcquiring Shares$90,278 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.13 out of 5 starsMedical Sector792nd out of 925 stocksSecurity Brokers & Dealers Industry25th out of 26 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Dominari.Read more about Dominari's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.01% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Dominari has recently decreased by 98.08%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldDominari does not currently pay a dividend.Dividend GrowthDominari does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOMH. Previous Next 1.8 News and Social Media Coverage News SentimentDominari has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Dominari this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for DOMH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dominari insiders have bought more of their company's stock than they have sold. Specifically, they have bought $90,278.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 9.74% of the stock of Dominari is held by insiders.Percentage Held by Institutions42.48% of the stock of Dominari is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dominari's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dominari is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dominari is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDominari has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Dominari's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. About Dominari Stock (NASDAQ:DOMH)Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.Read More DOMH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOMH Stock News HeadlinesMay 13 at 11:38 AM | investorplace.comDOMH Stock Earnings: Dominari Holdings Reported Results for Q1 2024May 4, 2024 | americanbankingnews.comDominari (NASDAQ:DOMH) vs. Interactive Brokers Group (NASDAQ:IBKR) Head-To-Head AnalysisApril 17, 2024 | finance.yahoo.comDominari Securities LLC Continues Expansion of Its Capital Market Group with Senior HiresApril 1, 2024 | investorplace.comDOMH Stock Earnings: Dominari Holdings Reported Results for Q4 2023March 15, 2024 | prnewswire.comDominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and ComplianceMarch 12, 2024 | prnewswire.comDominari Securities LLC Expands Investment Banking Practice with Appointment of Experienced Financial ExecutiveMarch 7, 2024 | prnewswire.comDominari Securities LLC Continues to Add Depth with Three New HiresMarch 7, 2024 | prnewswire.comDominari Securities LLC Continues to Add Depth with Three New HiresMarch 6, 2024 | prnewswire.comDominari Securities LLC Welcomes Wealth Management Team Gotham EquitiesMarch 5, 2024 | finance.yahoo.comDominari Securities LLC Welcomes Another Wealth Management TeamFebruary 15, 2024 | finance.yahoo.comDominari Securities LLC Serves as Lead Underwriter for $5 Million Initial Public Offering for Unusual MachinesFebruary 15, 2024 | prnewswire.comDominari Securities LLC Serves as Lead Underwriter for $5 Million Initial Public Offering for Unusual MachinesJune 30, 2023 | finance.yahoo.comDominari Securities CEO, Kyle Wool, Shares Positive View of IPO Market on "Varnay & Co."June 21, 2023 | finance.yahoo.comDominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"June 5, 2023 | finance.yahoo.comKyle Wool, CEO of Dominari Securities, To Appear on Fox Business' Mornings With Maria TodayMay 30, 2023 | finance.yahoo.comKyle Wool, CEO of Dominari Securities, To Appear on Fox Business' Varnay & Co. TodayMay 24, 2023 | finance.yahoo.comDominari Inc. Expands Kyle Wool's Role at Company to Include CEO of Dominari SecuritiesApril 27, 2023 | finance.yahoo.comDominari Financial CEO, Kyle Wool, Scheduled to Appear on Fox Business Network's "Mornings with Maria" on April 27April 18, 2023 | finance.yahoo.comDominari Securities Acquires Broker Team with $700 Million in Assets Under ManagementApril 7, 2023 | marketwatch.comThursday 4/6 Insider Buying Report: PL, DOMHApril 3, 2023 | finance.yahoo.comDominari Holdings Appoints George Way Chief Financial OfficerMarch 28, 2023 | finance.yahoo.comKyle Wool Named CEO of Dominari FinancialSee More Headlines Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today5/13/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Security brokers & dealers Sub-IndustryN/A Current SymbolNASDAQ:DOMH CUSIPN/A CIK12239 WebN/A Phone(112) 745-1374Fax703-992-9348Employees26Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-22,880,000.00 Net Margins-721.11% Pretax Margin-721.11% Return on Equity-38.40% Return on Assets-35.22% Debt Debt-to-Equity RatioN/A Current Ratio15.89 Quick Ratio15.89 Sales & Book Value Annual Sales$2.04 million Price / Sales5.96 Cash FlowN/A Price / Cash FlowN/A Book Value$9.90 per share Price / Book0.21Miscellaneous Outstanding Shares5,930,000Free Float5,357,000Market Cap$12.16 million OptionableNot Optionable Beta0.92 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Anthony C. Hayes Esq. (Age 56)CEO & Chairman Comp: $1MMr. Kyle Michael Wool (Age 46)President & Director Comp: $600.36kMr. George Michael Way CPA (Age 56)Chief Financial Officer Mr. Christopher Devall (Age 41)Chief Operating Officer Comp: $350kMr. Matthew B. McCullough (Age 38)General Counsel Mr. Jaime Mercado Jr.Chief Compliance OfficerMore ExecutivesKey CompetitorsMonopar TherapeuticsNASDAQ:MNPRTrinity BiotechNASDAQ:TRIBKiora PharmaceuticalsNASDAQ:KPRXAesthetic Medical International Holdings GroupNASDAQ:AIHRedHill BiopharmaNASDAQ:RDHLView All CompetitorsInsidersKyle Michael WoolBought 8,500 shares on 4/8/2024Total: $25,415.00 ($2.99/share)Anthony HayesBought 3,944 shares on 4/4/2024Total: $10,333.28 ($2.62/share)Kyle Michael WoolBought 19,000 shares on 4/4/2024Total: $54,530.00 ($2.87/share)Christopher Franklin DevallBought 7,000 shares on 12/26/2023Total: $17,850.00 ($2.55/share)Kyle Michael WoolBought 5,000 shares on 12/26/2023Total: $13,000.00 ($2.60/share)View All Insider Transactions DOMH Stock Analysis - Frequently Asked Questions How have DOMH shares performed in 2024? Dominari's stock was trading at $2.59 at the beginning of 2024. Since then, DOMH shares have decreased by 20.8% and is now trading at $2.05. View the best growth stocks for 2024 here. When is Dominari's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our DOMH earnings forecast. How were Dominari's earnings last quarter? Dominari Holdings Inc. (NASDAQ:DOMH) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($0.35) earnings per share for the quarter. The business earned $1.37 million during the quarter. Dominari had a negative trailing twelve-month return on equity of 38.40% and a negative net margin of 721.11%. How do I buy shares of Dominari? Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DOMH) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dominari Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.